QUCY Quantum Cyber

BULLISH Impact: 7/10 PRESS-RELEASE
Horizon weeks Filed May 26, 2026 Processed 14d 18h ago Wire GlobeNewswire
Press release: regulatory
Latest settled — T+5d
QUCY ▼ -35.73% at T+5d
LONG call ✗ call lost -35.73% · α vs SPY -36.82% · entry $3.47 → $2.23
Next anchor: T+20d in 14d
Last close $2.10 (close Jun 8) · -39.48% from $3.47 entry
Entry anchored
May 26, 07:12 AM ET
via Databento tick
T+1d
-15.56%
call -15.56% · α -15.58%
$2.93
settled 14d ago
T+5d
-35.73%
call -35.73% · α -36.82%
$2.23
settled 8d ago
T+20d
call — · α —
in 14d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Quantum Cyber announced that all outstanding warrants have been fully exercised, generating over $15 million in gross proceeds. The company is now debt-free with no exercisable warrants remaining, and plans to use the funds for R&D, commercialization, and strategic acquisitions in the autonomous defense sector.

Key Financial Metrics

Deal Value
$15.0M

Actionable Insight

The elimination of warrant overhang and debt, combined with a $15M cash infusion, removes two major overhangs and provides a clean balance sheet for M&A. Watch for acquisition announcements and next quarterly update on cash burn and pipeline progress.

Key Facts

  • Warrant holders fully exercised outstanding warrants, yielding over $15 million in gross proceeds.
  • Company is now debt-free with no remaining exercisable warrants.
  • Current shares outstanding: 22,767,254.
  • Proceeds to fund R&D expansion, commercialization team build-out, and strategic acquisitions.
  • Management cites alignment with $55 billion U.S. DoD drone procurement budget and counter-UAS market growth from $3.1B to $10.6B by 2030.

Financial Impact

Over $15 million in gross proceeds from warrant exercises; all debt retired.

cashdebtdilution

Risk Factors

  • Execution risk on deploying proceeds into R&D and acquisitions.
  • Dilution from the 22.8M shares outstanding may pressure near-term stock price.
  • Forward-looking statements on market growth may not materialize.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (6 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3300983
19 reports for QUCY
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +16.85%Apr 28, 2026
Filters
Rows
Reports for QUCY — sortable, filterable
Type Now
Jun 5, 2026
4d ago
8-K
NEUTRAL ★ 3/10
$2.19 awaiting T+1awaiting T+1$2.10 (−3.89%)
Jun 4, 2026
5d ago
S-3
BEARISH ★ 7/10
$2.33 $2.20▲ +5.58%▲ +2.98%$2.10 (+9.87%)
Jun 3, 2026
6d ago
8-K
MIXED ★ 5/10
$2.46 $2.33▼ −5.28%▼ −5.68%$2.10 (−14.63%)
Jun 3, 2026
6d ago
Press Release
NEUTRAL ★ 3/10
$2.46 $2.33▼ −5.28%▼ −5.68%$2.10 (−14.63%)
Jun 2, 2026
7d ago
Press Release
NEUTRAL ★ 4/10
$2.45 $2.46▲ +0.41%▲ +1.10%$2.10 (−14.29%)
May 27, 2026
13d ago
Press Release
NEUTRAL ★ 4/10
$2.93 $2.98▲ +1.71%▲ +1.15%$2.10 (−28.33%)
May 26, 2026
14d ago
Press Release
BULLISH ★ 7/10
$3.47 $2.93▼ −15.56%▼ −15.58%$2.10 (−39.48%)
May 22, 2026
18d ago
144
NEUTRAL ★ 3/10
$3.33 $3.47▲ +4.20%▲ +3.62%$2.10 (−36.94%)
May 20, 2026
20d ago
Press Release
NEUTRAL ★ 4/10
$3.29 $3.56▲ +8.21%▲ +8.01%$2.10 (−36.17%)
May 18, 2026
22d ago
144
BEARISH ★ 5/10
$2.52 $3.29▼ −30.56%▼ −29.52%$2.10 (+16.67%)
Showing 10 of 19

US Market Status

Market Closed — Opens in 7h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access